Geanncarlo Lugo-Villarino

7PUBLICATIONS
44CO-AUTHORS
Tissue engineeringMedical devicesBiomaterialsMedical infection agents (incl. prions)Microbial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 11, 2026
Dual human lung models reveal compartment-specific activity of anti-tuberculosis drugs and host-directed therapies.

|Feb 19, 2026
Glycolysis inhibition in tuberculosis-driven metabolic rewiring reduces HIV-1 spread in macrophages.

Zoï Vahlas, Clara Deyts, Steven Fried

|Oct 04, 2021
Mycobacteria-host interactions in human bronchiolar airway organoids.

Nino Iakobachvili, Stephen Adonai Leon-Icaza, Kèvin Knoops

|Sep 13, 2021
Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and supports Pseudomonas aeruginosa-driven pathology.

Salimata Bagayoko, Stephen Adonai Leon-Icaza, Miriam Pinilla

|Sep 04, 2021
A Pulmonary Lactobacillus murinus Strain Induces Th17 and RORγt+ Regulatory T Cells and Reduces Lung Inflammation in Tuberculosis.

Lucie Bernard-Raichon, André Colom, Sarah C Monard

|Oct 01, 2020
Fatty acid oxidation of alternatively activated macrophages prevents foam cell formation, but Mycobacterium tuberculosis counteracts this process via HIF-1α activation.

Melanie Genoula, José Luis Marín Franco, Mariano Maio

Pageof 2

Frequent Collaborators

5 joint publications

Olivier Neyrolles

3 joint publications

Christel Vérollet

3 joint publications

Céline Cougoule

3 joint publications

Stephen Adonai Leon-Icaza